These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16358156)

  • 1. [Cardiovascular manifestations in patients infected with the human immunodeficiency virus].
    Hajjar LA; Calderaro D; Yu PC; Giuliano I; Lima EM; Barbaro G; Caramelli B
    Arq Bras Cardiol; 2005 Nov; 85(5):363-77. PubMed ID: 16358156
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV and cardiovascular medicine.
    Prendergast BD
    Heart; 2003 Jul; 89(7):793-800. PubMed ID: 12807864
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular manifestations of HIV infection.
    Barbaro G
    J R Soc Med; 2001 Aug; 94(8):384-90. PubMed ID: 11461981
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy.
    Haser GC; Sumpio B
    J Vasc Surg; 2017 Mar; 65(3):849-859. PubMed ID: 26994951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated pulmonary arterial hypertension: considerations for pulmonary vascular diseases in the developing world.
    Butrous G
    Circulation; 2015 Apr; 131(15):1361-70. PubMed ID: 25869003
    [No Abstract]   [Full Text] [Related]  

  • 6. Resolution of human immunodeficiency virus type 1 infection-related severe pulmonary hypertension in a very low-birth-weight infant.
    Feiterna-Sperling C; Hüseman D; Timme J; Bührer C; Obladen M
    Pediatr Infect Dis J; 2008 Jun; 27(6):564-7. PubMed ID: 18449067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in HIV-associated cardiovascular diseases in Africa.
    Syed FF; Sani MU
    Heart; 2013 Aug; 99(16):1146-53. PubMed ID: 23680889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-associated cardiovascular complications: a new challenge for emergency physicians.
    Barbaro G; Fisher SD; Giancaspro G; Lipshultz SE
    Am J Emerg Med; 2001 Nov; 19(7):566-74. PubMed ID: 11699002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular monitoring of HIV-infected patients.
    Barbaro G
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):379; author reply 380. PubMed ID: 16645420
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and biological insights in HIV-associated cardiovascular disease in the era of highly active antiretroviral therapy.
    Murphy RL; Barbaro G
    AIDS; 2003 Apr; 17 Suppl 1():S1-3. PubMed ID: 12870524
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular risks in HIV patients.
    Hedner T; Oparil S; Narkiewicz K; Os I
    Blood Press; 2010 Dec; 19(6):325-7. PubMed ID: 21080761
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular disease associated with human immunodeficiency virus: a review.
    Costa LA; Almeida AG
    Rev Port Cardiol; 2015; 34(7-8):479-91. PubMed ID: 26162286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Prevalence of Echocardiographic Abnormalities among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.
    Mondy KE; Gottdiener J; Overton ET; Henry K; Bush T; Conley L; Hammer J; Carpenter CC; Kojic E; Patel P; Brooks JT;
    Clin Infect Dis; 2011 Feb; 52(3):378-86. PubMed ID: 21217185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial and platelet function alterations in HIV-infected patients.
    Gresele P; Falcinelli E; Sebastiano M; Baldelli F
    Thromb Res; 2012 Mar; 129(3):301-8. PubMed ID: 22192157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mediators in HIV-associated cardiovascular disease: a focus on cytokines and genes.
    Fisher SD; Bowles NE; Towbin JA; Lipshultz SE
    AIDS; 2003 Apr; 17 Suppl 1():S29-35. PubMed ID: 12870528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.
    Wang T; Yi R; Green LA; Chelvanambi S; Seimetz M; Clauss M
    Cardiovasc Pathol; 2015; 24(5):279-82. PubMed ID: 26233281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension in individuals with HIV infection.
    Petrosillo N; Chinello P; Cicalini S
    AIDS; 2006 Oct; 20(16):2128-9. PubMed ID: 17053364
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV infection, highly active antiretroviral therapy and the cardiovascular system.
    Barbaro G
    Cardiovasc Res; 2003 Oct; 60(1):87-95. PubMed ID: 14522410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pavia consensus statement.
    Volberding PA; Murphy RL; Barbaro G; Barbarini G; Bruno R; Cirelli A; Currie PF; Di Lorenzo G; Fantoni M; Filiced G; Galli M; Grisorio B; Moroni M; Recusani F; Sacchi P; Scevola D; Stein JH; Torre D; Vittecoq D
    AIDS; 2003 Apr; 17 Suppl 1():S170-9. PubMed ID: 12870544
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular disease prevention and treatment in patients with human immunodeficiency virus.
    Magen E; Elbirt D; Sthoeger Z
    Isr Med Assoc J; 2005 Apr; 7(4):252-6. PubMed ID: 15847207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.